Home › Funds › Simplify Asset Management Inc. › VRTX

Simplify Asset Management Inc. position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

Simplify Asset Management Inc. reported holding 10,428 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$5.5M, representing 0.09% of its reported portfolio and ranking #39 among its reported holdings. Simplify Asset Management Inc. has disclosed VRTX holdings in 10 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)10.43K sh
Reported value held$5.45M
Portfolio Weight0.09%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Simplify Asset Management Inc.'s VRTX position evolved

Simplify Asset Management Inc. first disclosed a stake in VRTX in Q3 2023 at 7,425 shares (US$2.6M). The position peaked in Q4 2025 at 17,492 shares, worth US$7.9M. Across 10 filings, Simplify Asset Management Inc. increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 10,428 shares valued at US$5.5M. Notable position changes include a 69% trim in Q4 2023 (shares rose 2% over the following quarter), a 75% trim in Q1 2025 (shares fell 8% over the following quarter), a 1328% increase in Q4 2025 (shares fell 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 7.42K $2.58M New
Q4 2023 2.31K $940.32K Reduce
Q4 2024 4.69K $1.89M New
Q1 2025 1.20K $579.36K Reduce
Q2 2025 1.08K $481.26K Reduce
Q3 2025 1.23K $479.76K Add
Q4 2025 17.49K $7.93M Add
Q1 2026 7.94K $3.54M Reduce
Q2 2026 10.46K $5.19M Add
Q3 2026 10.43K $5.45M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 32 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$13.58B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has Simplify Asset Management Inc. held VRTX?

Simplify Asset Management Inc. has disclosed VRTX holdings in 10 of the last 13 reported quarters, going back to Q3 2023.

What is Simplify Asset Management Inc.'s current position in VRTX?

As of Q3 2026, Simplify Asset Management Inc. holds 10.43K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $5.45M, representing 0.09% of its reported portfolio and ranking #39.

Has Simplify Asset Management Inc. been buying or selling VRTX?

In the latest 13F filing (Q3 2026), Simplify Asset Management Inc. held unchanged its position in VRTX. The position peaked in Q4 2025 at 17.49K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.